GLP-1 receptor agonists, the drug class behind Ozempic, Wegovy, and Mounjaro, have moved from a pharmaceutical story to a commercial one, and the CPS executives who have not yet treated them as a business problem are running out of time to get ahead of them
General Wellness and Anti-Aging Protocol Dose: 0.5 to 1.5 mg per day Route: Subcutaneous Frequency: Daily or every other day Cycle: 30 days on, 30 days off Expected results: Improved skin quality, energy, and recovery over 4 to 8 weeks Best for: Maintenance, systemic anti-inflammatory support, preventive use This lower-dose protocol suits individuals who have completed a targeted cycle (skin, hair, or healing) and want to maintain results
The gastrointestinal distress that accompanies treatment can create anticipatory anxiety about nighttime symptoms
doi: 10.1101/cshperspect.a016295 43 HeinrichPCCastellJVAndusT
(2012) reported non-significant results for overall ABC scores, but significant results for the ABC social withdrawal score
